- Ophthalmic data management plus AI analysis
- Targets ophthalmology needs rather than a generic suite
- Scales to organization-wide healthcare rollouts
RetinAI
Ophthalmic data management with AI analysis
SF7.2
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Support multi disease retinal screeningEye care clinics and research programs
Support multi disease retinal screeningEye care clinics and research programs
Best for
Eye care clinics and research programs
Pricing
Custom
SoftFinders Score
7.2 / 10
Overview
What is RetinAI?
RetinAI is an AI ophthalmology platform for eye care clinics and research programs, combining ophthalmic data management with analysis across screening workflows.
- Clinical role: It supports retinal screening and care routing rather than replacing ophthalmologists, while specialist follow-up remains essential for every positive screen surfaced through the workflow.
- Best-fit environment: Clinics and research programs gain value when ophthalmic data management and AI analysis align with established imaging workflows.
- Implementation checks: Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites.
- Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, so value depends on imaging data workflow.
A focused pilot around one workflow is usually the clearest way to assess fit before wider adoption.
KEY FEATURES
What you get out of the box
Primary Care Use
Designed for primary care screening settings
Care Routing
Routes positive screens to ophthalmology
Patient Reports
Generates patient-facing screening reports
Image Quality
Checks captured image quality before analysis
Retinal Screening
Screens retinal images for disease indicators
Autonomous Detection
Autonomous detection of diabetic retinopathy
USE CASES
Where teams put it to work
Support multi-disease retinal screening
Standardize diabetic eye screening programs
Generate patient-facing screening reports
Screen for diabetic retinopathy at scale
Bring eye screening into primary care
Route positive screens to ophthalmology
Editorial Take
What we like, and what to verify
- Value depends on imaging data workflow
- Positive screens need specialist follow-up
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Mona.health SF 7
Why consider it
Retinal screening detection for eye programs
Sully.ai SF 7.6
Why consider it
All-in-one AI scribe and clinician assistant
Tali AI SF 7.5
Why consider it
Voice AI scribe with built-in medical search
Doximity GPT SF 7.4
Why consider it
Free clinical writing assistant for verified physicians
athenaOne Ambient Notes SF 7.7
Why consider it
Ambient visit notes built into athenaOne
FAQ